0001127602-14-027607.txt : 20140911 0001127602-14-027607.hdr.sgml : 20140911 20140911164103 ACCESSION NUMBER: 0001127602-14-027607 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140909 FILED AS OF DATE: 20140911 DATE AS OF CHANGE: 20140911 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERSTEIN DAVID L CENTRAL INDEX KEY: 0001242986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36172 FILM NUMBER: 141098508 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-09-09 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242986 BERSTEIN DAVID L C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 SVP, GC and Chief IP Officer Common Stock 2014-09-09 4 M 0 7825 5.23 A 147983 D Common Stock 2014-09-09 4 F 0 7118 5.75 D 236741 D Employee Stock Option (Right to Buy) 5.23 2014-09-09 4 M 0 7825 0 D 2006-09-09 2014-09-09 Common Stock 7825 11375 D Shares were acquired upon the exercise of outstanding stock options at $5.23 per share. Represents shares withheld to pay for the exercise cost related to the exercise of outstanding options. Options were exercisable on 09/09/2006 as to 50% of the options awarded, on 09/09/2007 as to 75% of the options awarded and on 09/09/2008 as to 100% of the options awarded. /s/Edward M. Fitzgerald, Attorney-in-Fact 2014-09-11